Citations 1
Dose analysis of ASSURE (E2805): Adjuvant sorafenib or sunitinib for unfavorable renal carcinoma, an ECOG-ACRIN-led, NCTN phase 3 trial.
Manola, Judith , Wood, Christopher G. , Jewett, Michael A.S. , Coomes, Bob, Kuzel, Timothy M. , Sexton, Wade J. , Wong, Yu‐Ning, Пили, Роберто , DiPaola, Robert S. , Group, ECOG/ ACRIN 2805 Authors, Haas, Naomi B , Flaherty, Keith T. , Uzzo, Robert G. , Atkins, Michael B. , Dutcher, Janice P. , Kane, Christopher J. , Matin, Surena F. , Choueiri, Toni K. , Puzanov, Igor , Kohli, Manish , Stadler, Walter M. , Group, ECOG/ ACRIN 2805 Authors
Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 4508-4508
